Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Deyn

Showing results (221-230 of 493) with videos related to

Pageof 50
Sort By:
Neurochemistry International|December 29, 2009
Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patientsRaf Brouns, An Van Hemelrijck, Wilhelmus H Drinkenburg, et al.
Neurology|August 1, 2007
Galantamine treatment of vascular dementia: a randomized trialA P Auchus, H R Brashear, S Salloway, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2016
Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's DiseaseYannick Vermeiren, Jana Janssens, Tony Aerts, et al.
European Journal of Clinical Investigation|October 31, 2017
Dynamics of neutrophil gelatinase-associated lipocalin plasma and cerebrospinal fluid concentrations in older malesPetrus J W Naudé, Doortje W Dekens, Ulrich L M Eisel, et al.
Human Mutation|October 15, 2008
Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementiaKristel Sleegers, Karolien Bettens, Nathalie Brouwers, et al.
Human Mutation|February 5, 2009
No association between CALHM1 and risk for Alzheimer dementia in a Belgian populationKristel Sleegers, Nathalie Brouwers, Karolien Bettens, et al.
Journal of Alzheimer'S Disease : JAD|August 22, 2013
Behavioral syndromes in mild cognitive impairment and Alzheimer's diseaseStefan Van der Mussele, Peter Mariën, Jos Saerens, et al.
Biochemical Medicine and Metabolic Biology|February 1, 1993
Effect of urease-induced hyperammonemia on metabolism of guanidino compoundsK L Meert, D R Deshmukh, B Marescau, et al.
Molecular Genetics and Metabolism|February 24, 2010
Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemiaJoshua L Deignan, Peter P De Deyn, Stephen D Cederbaum, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiencyP P De Deyn, B Marescau, J J Cuykens, et al.
Pageof 50

Showing results (221-230 of 493) with videos related to

Sort By:
Pageof 50
Neurochemistry International|December 29, 2009
Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patientsRaf Brouns, An Van Hemelrijck, Wilhelmus H Drinkenburg, et al.
Neurology|August 1, 2007
Galantamine treatment of vascular dementia: a randomized trialA P Auchus, H R Brashear, S Salloway, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2016
Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's DiseaseYannick Vermeiren, Jana Janssens, Tony Aerts, et al.
European Journal of Clinical Investigation|October 31, 2017
Dynamics of neutrophil gelatinase-associated lipocalin plasma and cerebrospinal fluid concentrations in older malesPetrus J W Naudé, Doortje W Dekens, Ulrich L M Eisel, et al.
Human Mutation|October 15, 2008
Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementiaKristel Sleegers, Karolien Bettens, Nathalie Brouwers, et al.
Human Mutation|February 5, 2009
No association between CALHM1 and risk for Alzheimer dementia in a Belgian populationKristel Sleegers, Nathalie Brouwers, Karolien Bettens, et al.
Journal of Alzheimer'S Disease : JAD|August 22, 2013
Behavioral syndromes in mild cognitive impairment and Alzheimer's diseaseStefan Van der Mussele, Peter Mariën, Jos Saerens, et al.
Biochemical Medicine and Metabolic Biology|February 1, 1993
Effect of urease-induced hyperammonemia on metabolism of guanidino compoundsK L Meert, D R Deshmukh, B Marescau, et al.
Molecular Genetics and Metabolism|February 24, 2010
Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemiaJoshua L Deignan, Peter P De Deyn, Stephen D Cederbaum, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiencyP P De Deyn, B Marescau, J J Cuykens, et al.
Pageof 50